Enter multiple symbols separated by commas

Stocks Illumina Inc


  • Considering Illumina just adopted a poison pill defense strategy, you might think a deal with Roche is out of the question. But Karen Finerman says it's not.

  • Finerman's Fine Print: Illumina Rejects Roche Wednesday, 8 Feb 2012 | 5:29 PM ET
    Finerman's Fine Print: Illumina Rejects Roche

    Karen Finerman, Metropolitan Capital Advisors, and Fast Money trader, provides insight on what's next for Illumina, on the heels its recent rejection of Roche's offer.

  • Roche Offer for Illumina Fair, Compelling: CEO Friday, 3 Feb 2012 | 12:44 PM ET

    Roche is willing to spend $5.7 billion on what could be a hostile takeover of Illumina to get into the gene-sequencing market, CEO Severin Schwan told CNBC Friday.

  • Roche CEO on Illumina Deal Friday, 3 Feb 2012 | 11:25 AM ET
    Roche CEO on Illumina Deal

    Insight on the value that will be created by a transaction with Illumina, with Severin Schwan, Roche CEO, who discusses Roche's offer for Illumina.

  • Following are moves you might have missed. Find out why shares of  D.R. Horton and Honeywell popped while Illumina and Altria dropped.

  • Major Wave of Biotech Mergers Expected Thursday, 26 Jan 2012 | 2:48 PM ET

    Amgen and Celgene, looking to boost oncology offerings, announced separate deals for small biotech companies Thursday, the latest in what analysts expect to be a major wave of biotech mergers.

  • Stocks End Sharply Higher After Fed News Wednesday, 25 Jan 2012 | 7:57 PM ET

    Stocks ended near session highs Wednesday, reversing their early declines, as the market cheered news that the Fed will not raise interest rates until at least 2014 in addition to maintaining its highly accommodative stance to support the recovery.

  • Ways to Win In This Market Wednesday, 25 Jan 2012 | 6:43 PM ET

    Cramer ticks off the many winning trades today.

  • Finerman’s Fine Print: Roche Hostility Wednesday, 25 Jan 2012 | 6:29 PM ET

    Illumina landed squarely on Karen Finerman’s trader radar Wednesday with the company in the cross hairs of a hostile bid from Roche.

  • Roche Makes $5.7B Bid for Illumina Wednesday, 25 Jan 2012 | 5:21 PM ET
    Roche Makes $5.7B Bid for Illumina

    Keith Moore, MKM Partners, discusses how to play Roche's hostile bid for gene sequencer, Illumin, saying ILMN is likely to fight the takeover. Also an update on SanDisk's earnings, with the Fast Money crew.

  • Finerman's Fine Print: Roche Hostility Wednesday, 25 Jan 2012 | 5:18 PM ET
    Finerman's Fine Print: Roche Hostility

    Fast Money trader Karen Finerman explains what's behind Roche's tender offer for Illumina; and the best way to play the biotech takeout trend.

  • Futures Mixed Ahead of Fed; Apple Surges Wednesday, 25 Jan 2012 | 9:17 AM ET

    U.S. stock index futures struggled for direction Wednesday as investors digested a handful of corporate earnings and ahead of the Federal Reserve's policy statement.

  • What's Shaking: Wednesday's Early Movers Wednesday, 25 Jan 2012 | 8:36 AM ET

    Take a look at some of Wednesday morning's early movers:

  • Stocks Close Day Lower But Gain for Week Friday, 7 Oct 2011 | 4:04 PM ET

    Despite a failed attempt at the end of Friday's session to close the week out on a positive note, stocks finished higher on some tepid signs of recovery for the US economy.

  • Currency Trades Friday, 7 Oct 2011 | 12:51 PM ET
    Currency Trades

    The Fast Money traders discuss today's pops and drops. Also, sharing perspective on where the euro is headed, with Willie Williams, Societe General director.

  • Cramer Answers Your Questions Friday, 30 Sep 2011 | 7:26 PM ET

    Yes, it's time for "Mad Mail."

  • Cramer makes the call on viewers' favorite stocks.

  • Top Analyst Derik De Bruin Reveals Top Picks Tuesday, 12 Oct 2010 | 6:22 PM ET

    Shortly after being named top life sciences analyst, Derik De Bruin dropped by Fast Money with his top picks in the space.

  • Pops & Drops: Evergreen Solar, TiVo... Thursday, 2 Jul 2009 | 6:26 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Evergreen Solar and Elan popped while TiVo and Southwest dropped.

  • Stock Picks: 6 Health Care—Stimulus Plays Wednesday, 29 Apr 2009 | 5:27 PM ET

    Investors can benefit from certain health care companies that will be boosted by the stimulus package, said Les Funtleyder, health care strategist of Miller Tabak.